About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Ptpn11
protein tyrosine phosphatase, non-receptor type 11
MGI:99511
93 phenotypes from multigenic genotypes
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Dmp1m1Btlr/Dmp1m1Btlr
Ptpn11m1Btlr/Ptpn11m1Btlr
Sdad1m1Btlr/Sdad1m1Btlr
C57BL/6J-Dmp1m1Btlr Sdad1m1Btlr Ptpn11m1Btlr/Btlr
decreased bone mineral density J:309727
short tibia J:309727
Egfrwa2/Egfrwa2
Ptpn11tm1Paw/Ptpn11+
involves: 129S1/Sv * 129X1/SvJ * B6EiC3Sn a/A-Egfrwa2 Wnt3avt * C57BL/6
abnormal breathing pattern J:75413
abnormal hair follicle development J:75413
abnormal hair follicle morphology J:75413
abnormal hair follicle orientation J:75413
abnormal hair growth J:75413
abnormal intestine morphology J:75413
abnormal lung development J:75413
abnormal muscle morphology J:75413
abnormal skin condition J:75413
atelectasis J:75413
cachexia J:75413
decreased hair follicle number J:75413
decreased subcutaneous adipose tissue amount J:75413
dry skin J:75413
epidermal atrophy J:75413
eyelids open at birth J:75413
flaky skin J:75413
intestinal hypoperistalsis J:75413
postnatal growth retardation J:75413
postnatal lethality, incomplete penetrance J:75413
thick pulmonary interalveolar septum J:75413
thin epidermis J:75413
thin skin J:75413
waved hair J:75413
Egfrwa2/Egfrwa2
Ptpn11tm1Rbn/Ptpn11+
involves: 129 * B6EiC3Sn-a/A-Egfrwa2 Wnt3avt
abnormal impulse conducting system conduction J:60750
aortic valve regurgitation J:60750
aortic valve stenosis J:60750
congestive heart failure J:60750
enlarged semilunar valve J:60750
eyelids open at birth J:60750
increased left ventricle diastolic pressure J:60750
increased left ventricle systolic pressure J:60750
increased systemic arterial blood pressure J:60750
myocardium hypertrophy J:60750
perinatal lethality, incomplete penetrance J:60750
prolonged PR interval J:60750
prolonged QRS complex duration J:60750
prolonged QT interval J:60750
prolonged RR interval J:60750
prolonged ST segment J:60750
thick aortic valve J:60750
thick pulmonary valve J:60750
Egr2tm2(cre)Pch/Egr2+
Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky/?
Ptpn11tm1.1Wbm/Ptpn11tm1.1Wbm
involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6
abnormal myelination J:207470
Egr2tm2(cre)Pch/Egr2+
Gt(ROSA)26Sortm8(Map2k1*,EGFP)Rsky/?
Ptpn11tm1.1Wbm/Ptpn11tm1.1Wbm
involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6
hypermyelination J:207470
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
Ptpn11tm1.1Rbns/Ptpn11tm1.1Rbns
H2az2Tg(Wnt1-cre)11Rth/H2az2+
B6.Cg-Ptpn11tm1.1Rbns Gt(ROSA)26Sortm1Sor H2az2Tg(Wnt1-cre)11Rth
decreased cardiac neural crest cell number J:150835
impaired cranial neural crest cell differentiation J:150835
Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky/?
Ptpn11tm1.1Wbm/Ptpn11tm1.1Wbm
Tg(Dhh-cre)1Mejr/0
involves: 129P2/OlaHsd * C57BL/6 * FVB/N
abnormal myelination J:207470
Gt(ROSA)26Sortm8(Map2k1*,EGFP)Rsky/?
Ptpn11tm1.1Wbm/Ptpn11tm1.1Wbm
Tg(Dhh-cre)1Mejr/0
involves: 129P2/OlaHsd * C57BL/6 * FVB/N
hypermyelination J:207470
Krastm4Tyj/Krastm4Tyj
Ptpn11tm1Gsf/Ptpn11tm1Gsf
Tg(Six3-cre)69Frty/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2
abnormal cone electrophysiology J:174095
abnormal rod electrophysiology J:174095
decreased a-wave amplitude J:174095
decreased b-wave amplitude J:174095
normal vision/eye phenotype J:174095
Mapk1tm1Melo/Mapk1+
Tg(Myh7-Ptpn11*Q79R)11Rbns/0
involves: 129S2/SvPas * FVB/N
normal cardiovascular system phenotype J:123963
normal respiratory system phenotype J:123963
Mapk3tm1Gpg/Mapk3tm1Gpg
Tg(Myh7-Ptpn11*Q79R)11Rbns/0
involves: 129/Sv * FVB/N
normal cardiovascular system phenotype J:123963
normal respiratory system phenotype J:123963
Mpzl1em1Ambt/Mpzl1em1Ambt
Ptpn11tm4.2Bgn/Ptpn11tm4.2Bgn
B6.Cg-Mpzl1em1Ambt Ptpn11tm4.2Bgn
normal cardiovascular system phenotype J:301775
normal growth/size/body region phenotype J:301775
slow postnatal weight gain J:301775
Ptentm1Hwu/Ptentm1Hwu
Ptpn11tm1Gsf/Ptpn11tm1Gsf
Tg(Six3-cre)69Frty/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2
optic nerve atrophy J:174095
retina degeneration J:174095
retina ganglion cell degeneration J:174095
retina outer nuclear layer degeneration J:174095
thin retina ganglion layer J:174095
thin retina inner nuclear layer J:174095
thin retina outer nuclear layer J:174095
Ptpn11tm1Gsf/Ptpn11tm1Gsf
Stat3tm1Vpo/Stat3tm1Vpo
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA
increased circulating alanine transaminase level J:172422
increased incidence of tumors by chemical induction J:172422
liver inflammation J:172422
Ptpn11tm1Gsf/Ptpn11tm1Gsf
Stat3tm1Xyfu/Stat3tm1Xyfu
Tg(Six3-cre)69Frty/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2
retina degeneration J:174095
retina ganglion cell degeneration J:174095
retina outer nuclear layer degeneration J:174095
thin retina ganglion layer J:174095
thin retina inner nuclear layer J:174095
thin retina outer nuclear layer J:174095
thin retina outer plexiform layer J:174095
Tg(CAG-cat,-Ptpn11)1Rbns/0
Tg(Tek-cre)12Flv/0
involves: C3H * C57BL/6 * FVB/N
normal cardiovascular system phenotype J:142212
Tg(Myh6-Ptpn11)75Rbns/0
FVB.Cg-Tg(Myh6-Ptpn11)75Rbns
normal cardiovascular system phenotype J:123963
Tg(Myh6-Ptpn11*Q79R)197Rbns/0
FVB.Cg-Tg(Myh6-Ptpn11*Q79R)197Rbns
normal cardiovascular system phenotype J:123963
Tg(Myh6-Ptpn11*Q510E)#Krnz/0
FVB/N-Tg(Myh6-Ptpn11*Q510E)#Krnz
normal cardiovascular system phenotype J:181656
Tg(Myh7-Ptpn11)294Rbns/0
FVB.Cg-Tg(Myh7-Ptpn11)294Rbns
normal cardiovascular system phenotype J:123963
Tg(Myh7-Ptpn11*Q79R)11Rbns/0
FVB.Cg-Tg(Myh7-Ptpn11*Q79R)11Rbns
abnormal atrial thrombosis J:123963
abnormal cardiovascular system physiology J:123963
abnormal interventricular groove morphology J:123963
decreased cardiac muscle contractility J:123963
dilated heart atrium J:123963
dilated heart ventricle J:123963
increased heart weight J:123963
increased lung weight J:123963
premature death J:123963
thick ventricular wall J:123963
ventricular cardiomyopathy J:123963
ventricular septal defect J:123963
Tg(Myh7-Ptpn11*Q510E)#Krnz/0
FVB/N-Tg(Myh7-Ptpn11*Q510E)#Krnz
abnormal fetal cardiomyocyte morphology J:181656
abnormal heart echocardiography feature J:181656, J:222124
abnormal heart morphology J:181656
abnormal heart ventricle shape J:181656
abnormal interventricular groove morphology J:181656
abnormal myocardial fiber morphology J:222124
abnormal myocardial fiber physiology J:222124
cardiac hypertrophy J:181656, J:222124
cardiac interstitial fibrosis J:181656
cardiomyopathy J:181656
decreased cardiac muscle contractility J:181656
increased cardiac muscle contractility J:222124
increased heart atrium size J:181656
increased heart left atrium size J:181656
increased heart weight J:181656, J:222124
increased myocardial fiber size J:181656, J:222124
thick interventricular septum J:181656
ventricular septal defect J:181656

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/09/2024
MGI 6.23
The Jackson Laboratory